Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Breast Cancer
70%
Antidiabetic Agent
46%
Non Small Cell Lung Cancer
46%
Clinical Research
41%
Cohort Study
40%
Disease
38%
Observational Study
31%
Adverse Event
31%
All Cause Mortality
30%
Febrile Neutropenia
29%
Chemotherapy
28%
Spine Fracture
27%
Drug Utilization
26%
Hip Fracture
26%
Cancer Survival
25%
Thiazolidinedione
25%
Immune Checkpoint Inhibitor
25%
Granulocyte Colony Stimulating Factor
25%
Sodium Glucose Cotransporter 2 Inhibitor
25%
Comorbidity
25%
Retrospective Study
22%
Anticarcinogen
21%
Erlotinib
21%
Pioglitazone
18%
Bisphosphonic Acid Derivative
18%
Rosiglitazone
18%
Epidermal Growth Factor Receptor
18%
Overall Survival
17%
Gefitinib
17%
Lung Cancer
16%
Cardiovascular Disease
15%
Combination Therapy
15%
Brain Ischemia
14%
Oral Antidiabetic Agent
14%
Population Study
14%
Prevalence
14%
Health Status
14%
Progression Free Survival
14%
Infection
13%
Heart Infarction
12%
Injury Severity
12%
Calcium Channel Blocker
12%
Prescription Medication
12%
Botulinum Toxin
12%
Proton Pump Inhibitor
12%
Community Pharmacy
12%
Implant
12%
Case-Control Study
12%
Dengue
12%
Medicine and Dentistry
Targeted Therapy
50%
Systematic Review
50%
Health Care Cost
48%
Breast Cancer
45%
Drug Therapy
45%
Time Series Analysis
41%
Cancer Therapy
40%
Antidiabetic Agent
37%
Clinical Research
34%
Malignant Neoplasm
30%
Disease
30%
Erlotinib
25%
Gefitinib
25%
COVID-19
25%
Network Meta-Analysis
25%
Meta-Analysis
25%
Lung Cancer Survival
25%
Sodium Glucose Cotransporter 2 Inhibitor
25%
Non Small Cell Lung Cancer
25%
Diabetes
23%
Cancer Diagnosis
20%
Logistic Regression Analysis
19%
Epidermal Growth Factor Receptor
18%
Odds Ratio
17%
Endoscopy
16%
Maturity Onset Diabetes of the Young
16%
Adverse Event
15%
Anticarcinogen
15%
Lung Cancer
14%
Patient Care
14%
Diabetes Mellitus
14%
Cancer Registry
14%
Infection
13%
Electronic Health Record
13%
Case-Control Study
12%
Biological Therapy
12%
Spastic Diplegia
12%
Osteoporosis
12%
Particle Therapy
12%
Microwave Thermotherapy
12%
Hypersalivation
12%
Degenerative Disease
12%
Tyrosine-Kinase Inhibitor
12%
Drug-Eluting Stent
12%
Implant
12%
Brain Ischemia
12%
Radiation Therapy
12%
Attitude
12%
Cancer Mortality
12%
Hepatocellular Carcinoma
12%
Nursing and Health Professions
Breast Cancer
52%
Cancer Therapy
26%
Drug Therapy
20%
Area under the Curve
20%
National Health Insurance
20%
Receiver Operating Characteristic
18%
Febrile Neutropenia
16%
Cancer Diagnosis
14%
Physician
14%
Cohort Analysis
13%
Time Series Analysis
13%
Reimbursement
13%
Hip Fracture
12%
Brain Ischemia
12%
Spine Fracture
12%
Drug Eluting Stent
12%
Systematic Review
12%
Cancer Survival
12%
Adverse Event
12%
Meta Analysis
12%
Heart Infarction
12%
Hypersalivation
12%
Infertility Therapy
12%
Bare Metal Stent
12%
Cerebral Palsy
12%
Empathy
12%
Cancer Screening
12%
Social Media
12%
Non Small Cell Lung Cancer
12%
Patient Care
12%
Botulinum Toxin
12%
Statin (Protein)
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Granulocyte Colony Stimulating Factor
12%
Teleconsultation
12%
Health Care Facility
12%
Public Hospital
12%
Thorax Pain
12%
Acute Heart Infarction
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Logistic Regression Analysis
11%
Gefitinib
10%
Private Hospital
10%
Health Center
10%
Predictive Value
10%
Artificial Neural Network
9%
Botulinum Toxin A
9%
Erlotinib
8%
Comorbidity
8%
Emergency Ward
7%
